| |
| |
|
| Insider
Information: |
Flynn Daniel Lee |
| Relationship: |
Chief Scientific Officer |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
57,158 |
|
|
Indirect Shares
|
321,455 |
|
|
| Direct
Value |
$1,450,098 |
|
|
|
Indirect Value
|
$8,155,313 |
|
|
| Total
Shares |
378,613 |
|
|
| Total
Value |
$9,605,412 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 41.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Deciphera Pharmaceuticals, Inc. |
DCPH |
Chief Scientific Officer |
2023-06-16 |
57,158 |
2023-06-16 |
321,455 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-06-16 |
4 |
S |
$14.40 |
$23,835 |
D/D |
(1,655) |
57,158 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-02-16 |
4 |
S |
$15.10 |
$20,686 |
D/D |
(1,370) |
58,813 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,488 |
60,183 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-01-17 |
4 |
S |
$21.24 |
$51,043 |
D/D |
(2,403) |
43,695 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-06-16 |
4 |
S |
$10.75 |
$19,006 |
D/D |
(1,768) |
46,098 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-02-16 |
4 |
S |
$9.05 |
$12,362 |
D/D |
(1,366) |
47,866 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
49,232 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,100 |
28,732 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
S |
$48.87 |
$24,826 |
D/D |
(508) |
6,532 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,100 |
17,632 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-08-10 |
4 |
OE |
$1.89 |
$17,065 |
D/D |
9,029 |
237,475 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-07-22 |
4 |
OE |
$1.89 |
$245,700 |
D/D |
130,000 |
228,446 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,040 |
98,446 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-12-12 |
4 |
AS |
$60.00 |
$1,861,740 |
I/I |
(31,029) |
35,750 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-12-10 |
4 |
AS |
$55.00 |
$6,751,360 |
D/D |
(122,752) |
24,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-12-10 |
4 |
OE |
$1.89 |
$232,001 |
D/D |
122,752 |
118,430 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-12-09 |
4 |
AS |
$55.00 |
$1,659,625 |
D/D |
(30,175) |
24,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-12-09 |
4 |
OE |
$1.89 |
$57,031 |
D/D |
30,175 |
54,675 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-11-11 |
4 |
AS |
$48.01 |
$6,874,870 |
D/D |
(143,185) |
24,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-11-11 |
4 |
OE |
$1.89 |
$270,620 |
D/D |
143,185 |
167,685 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-11-08 |
4 |
AS |
$48.00 |
$467,616 |
D/D |
(9,742) |
24,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-11-08 |
4 |
OE |
$1.89 |
$18,412 |
D/D |
9,742 |
34,242 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-10-28 |
4 |
AS |
$40.00 |
$1,192,800 |
D/D |
(29,820) |
24,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-10-28 |
4 |
OE |
$1.89 |
$56,360 |
D/D |
29,820 |
54,320 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2019-08-13 |
4 |
OE |
$1.89 |
$232,672 |
D/D |
123,107 |
147,607 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
